nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—SLC12A1—Furosemide—dilated cardiomyopathy	0.354	0.407	CbGbCtD
Methyclothiazide—CA1—Furosemide—dilated cardiomyopathy	0.184	0.211	CbGbCtD
Methyclothiazide—CA4—Furosemide—dilated cardiomyopathy	0.173	0.199	CbGbCtD
Methyclothiazide—CA2—Furosemide—dilated cardiomyopathy	0.159	0.183	CbGbCtD
Methyclothiazide—Xanthopsia—Furosemide—dilated cardiomyopathy	0.0109	0.0835	CcSEcCtD
Methyclothiazide—Angiitis necrotising—Furosemide—dilated cardiomyopathy	0.0109	0.0835	CcSEcCtD
Methyclothiazide—Vasculitis necrotising—Furosemide—dilated cardiomyopathy	0.00951	0.0728	CcSEcCtD
Methyclothiazide—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00514	0.0393	CcSEcCtD
Methyclothiazide—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.00379	0.029	CcSEcCtD
Methyclothiazide—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00375	0.0287	CcSEcCtD
Methyclothiazide—Glycosuria—Furosemide—dilated cardiomyopathy	0.00246	0.0188	CcSEcCtD
Methyclothiazide—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00239	0.0183	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00215	0.0164	CcSEcCtD
Methyclothiazide—Vasculitis—Furosemide—dilated cardiomyopathy	0.00204	0.0156	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00203	0.0155	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00203	0.0155	CcSEcCtD
Methyclothiazide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00191	0.0146	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00187	0.0143	CcSEcCtD
Methyclothiazide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00174	0.0133	CcSEcCtD
Methyclothiazide—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00165	0.0126	CcSEcCtD
Methyclothiazide—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00162	0.0124	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0016	0.0123	CcSEcCtD
Methyclothiazide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00154	0.0118	CcSEcCtD
Methyclothiazide—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00153	0.0117	CcSEcCtD
Methyclothiazide—Purpura—Furosemide—dilated cardiomyopathy	0.0015	0.0115	CcSEcCtD
Methyclothiazide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00143	0.011	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00133	0.0102	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00132	0.0101	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00131	0.01	CcSEcCtD
Methyclothiazide—Cramp muscle—Furosemide—dilated cardiomyopathy	0.0013	0.00997	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00128	0.00979	CcSEcCtD
Methyclothiazide—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00124	0.00946	CcSEcCtD
Methyclothiazide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00123	0.00938	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.0012	0.0092	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00114	0.00873	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00113	0.00863	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00111	0.00846	CcSEcCtD
Methyclothiazide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00104	0.00796	CcSEcCtD
Methyclothiazide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00104	0.00794	CcSEcCtD
Methyclothiazide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00103	0.00791	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000991	0.00759	CcSEcCtD
Methyclothiazide—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000978	0.00748	CcSEcCtD
Methyclothiazide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000963	0.00737	CcSEcCtD
Methyclothiazide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000946	0.00724	CcSEcCtD
Methyclothiazide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00092	0.00704	CcSEcCtD
Methyclothiazide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000894	0.00684	CcSEcCtD
Methyclothiazide—Malnutrition—Furosemide—dilated cardiomyopathy	0.000871	0.00667	CcSEcCtD
Methyclothiazide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000864	0.00661	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000856	0.00655	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000846	0.00648	CcSEcCtD
Methyclothiazide—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000841	0.00644	CcSEcCtD
Methyclothiazide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000838	0.00641	CcSEcCtD
Methyclothiazide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000831	0.00636	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000829	0.00635	CcSEcCtD
Methyclothiazide—Rash—Spironolactone—dilated cardiomyopathy	0.000824	0.00631	CcSEcCtD
Methyclothiazide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000823	0.0063	CcSEcCtD
Methyclothiazide—Vision blurred—Furosemide—dilated cardiomyopathy	0.000821	0.00628	CcSEcCtD
Methyclothiazide—Headache—Spironolactone—dilated cardiomyopathy	0.000819	0.00626	CcSEcCtD
Methyclothiazide—Jaundice—Lisinopril—dilated cardiomyopathy	0.000815	0.00624	CcSEcCtD
Methyclothiazide—Agitation—Furosemide—dilated cardiomyopathy	0.000801	0.00613	CcSEcCtD
Methyclothiazide—Vertigo—Furosemide—dilated cardiomyopathy	0.000783	0.00599	CcSEcCtD
Methyclothiazide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000781	0.00597	CcSEcCtD
Methyclothiazide—Leukopenia—Furosemide—dilated cardiomyopathy	0.00078	0.00597	CcSEcCtD
Methyclothiazide—Nausea—Spironolactone—dilated cardiomyopathy	0.000776	0.00594	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000711	0.00544	CcSEcCtD
Methyclothiazide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00071	0.00543	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000696	0.00533	CcSEcCtD
Methyclothiazide—Anorexia—Furosemide—dilated cardiomyopathy	0.000678	0.00519	CcSEcCtD
Methyclothiazide—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000654	0.005	CcSEcCtD
Methyclothiazide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000639	0.00489	CcSEcCtD
Methyclothiazide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000629	0.00481	CcSEcCtD
Methyclothiazide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000618	0.00473	CcSEcCtD
Methyclothiazide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000616	0.00471	CcSEcCtD
Methyclothiazide—Constipation—Furosemide—dilated cardiomyopathy	0.000608	0.00465	CcSEcCtD
Methyclothiazide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000587	0.00449	CcSEcCtD
Methyclothiazide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000585	0.00448	CcSEcCtD
Methyclothiazide—Urticaria—Furosemide—dilated cardiomyopathy	0.000565	0.00432	CcSEcCtD
Methyclothiazide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000562	0.0043	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000534	0.00408	CcSEcCtD
Methyclothiazide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000524	0.00401	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000522	0.004	CcSEcCtD
Methyclothiazide—Asthenia—Furosemide—dilated cardiomyopathy	0.00051	0.0039	CcSEcCtD
Methyclothiazide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000509	0.00389	CcSEcCtD
Methyclothiazide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000487	0.00372	CcSEcCtD
Methyclothiazide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000479	0.00367	CcSEcCtD
Methyclothiazide—Dizziness—Furosemide—dilated cardiomyopathy	0.00047	0.0036	CcSEcCtD
Methyclothiazide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000464	0.00355	CcSEcCtD
Methyclothiazide—Constipation—Lisinopril—dilated cardiomyopathy	0.000456	0.00349	CcSEcCtD
Methyclothiazide—Vomiting—Furosemide—dilated cardiomyopathy	0.000452	0.00346	CcSEcCtD
Methyclothiazide—Rash—Furosemide—dilated cardiomyopathy	0.000448	0.00343	CcSEcCtD
Methyclothiazide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000448	0.00343	CcSEcCtD
Methyclothiazide—Headache—Furosemide—dilated cardiomyopathy	0.000445	0.00341	CcSEcCtD
Methyclothiazide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000424	0.00324	CcSEcCtD
Methyclothiazide—Nausea—Furosemide—dilated cardiomyopathy	0.000422	0.00323	CcSEcCtD
Methyclothiazide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000422	0.00323	CcSEcCtD
Methyclothiazide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000393	0.00301	CcSEcCtD
Methyclothiazide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000383	0.00293	CcSEcCtD
Methyclothiazide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000365	0.00279	CcSEcCtD
Methyclothiazide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000353	0.0027	CcSEcCtD
Methyclothiazide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000339	0.0026	CcSEcCtD
Methyclothiazide—Rash—Lisinopril—dilated cardiomyopathy	0.000336	0.00257	CcSEcCtD
Methyclothiazide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000336	0.00257	CcSEcCtD
Methyclothiazide—Headache—Lisinopril—dilated cardiomyopathy	0.000334	0.00256	CcSEcCtD
Methyclothiazide—Nausea—Lisinopril—dilated cardiomyopathy	0.000317	0.00242	CcSEcCtD
